Southlake BioTech Startup Gets $10M Grant from CPRIT for Technology That ‘Lights Up’ Cancer

OncoNano Medicine, a spinout of University of Texas Southwestern, uses pH as a biomarker to detect metastatic cancer. Its technology, which visualizes a tumor, could be a gamechanger.

Southlake-based biotech startup OncoNano Medicine says it’s received a $9.97 million grant from the Cancer Prevention and Research Institute of Texas (CPRIT) to expand uses for its innovative lead product, OHM-100, that “lights up” a tumor to distinguish it from normal tissue.

The grant is OncoNano’s third for its tumor biomarkers. The startup received $6 million from the Texas cancer agency in 2016 to advance ONM-100 and another $15.4 million in 2019 for ONM-500, an oncology product that also builds on the company’s proprietary pH-sensitive technology.

Ravi Srinivasan, PhD, CEO and Co-founder of OncoNano Medicine, Inc. [Photo courtesy OncoNano Medicine, Inc.]

CPRIT has been a partner since the company’s founding, OncoNano CEO and co-founder Ravi Srinivasan said. The new funding received from the agency for ONM-100’s pH-sensitive approach for imaging metastatic disease can solve “a tremendous unmet need,” he said in a statement.

Srinivasan explains that there are limited tools available that can allow doctors to visualize tumors that have metastasized, in particular, the “small and disperse ones often characteristic of metastatic disease.”

ONM-100 can help surgeons visualize cancer tumors during surgery by making cancerous tissue “light up,” according to Srinivasan. The imaging allows for more precision to ensure that tumors are fully removed during surgery. The product has been granted a fast track designation from the Food and Drug Administration (FDA) and is currently in Phase 2 clinical trials.

During the trials, researchers learned that ONM-100 also can be used to image and stage metastatic disease. That has the potential for saving lives: The improvement of visualization of metastatic disease—preoperatively and during surgery—is closely tied to patient survival.

OncoNano said metastatic disease represents some 45 to 50 percent of all cancer diagnoses, and it’s the cause of 90% of patient deaths. Better visualization of tumors is “critical for diagnosis, staging, therapeutic choice and efficacy,” it said.

Cindy WalkerPeach, PhD, chief product development officer at CPRIT, said the agency is looking forward to the clinical trials that clearly demonstrate favorable impact to cancer patient care.

“CPRIT continues to be impressed with OncoNano Medicine’s outcomes using their unique micelle technology to detect metastatic cancer,” she said in a statement.

OncoNano, which develops products to diagnose and treat cancer, has a number of products in the works. The other CPRIT funded product, ONM-500, uses the startup’s pH-sensitive micelle technology to deliver antigens to activate immunity for the treatment of cancers caused by the human papilloma virus (HPV).

OncoNano, launched in 2014, is a University of Texas Southwestern spinout. Using technology invented by Dr. Jinming Gao, professor of pharmacology and otolaryngology, and Dr. Baran D. Sumer, associate professor of otolaryngology, the two professors co-founded OncoNano along with Srinivasan, Dallas Innovates previously reported.

The company’s total funding is about $65 million, according to Crunchbase. Last year, Dallas Innovates reported that OncoNano’s Series A funding had reached $35 million in July, and received its second CPRIT grant later that summer.

OncoNano, a TechFW graduate, has many notable ties in the region in addition to its spinout from UTSW. As of late 2019, seven of the company’s 20 employees worked at Alcon, including chief financial officer Matthew Head. Of those seven, six worked at ZS Pharma, a one-time Coppell biopharmaceutical company that AstraZeneca acquired for $2.7 billion in 2015. Currently, CEO Srinivasan is chairman of the board of clinical-stage biotech company CAGE Bio, which expanded to UNT Health Science Center at Fort Worth in July.

Get on the list.
Dallas Innovates, every day.

Sign up to keep your eye on what’s new and next in Dallas-Fort Worth, every day.

One quick signup, and you’re done.
View previous emails.

R E A D   N E X T

  • BUiLT, nonprofit, Texas, North Texas, Dallas, Dallas-Fort Worth, DFW, Black talent, Black tech talent, Texas talent, North Texas talent, Dallas talent, Dallas-Fort Worth talent, DFW talent, talent attraction, Texas tech talent, North Texas tech talent, Dallas tech talent, Dallas-Fort Worth tech talent, DFW tech talent, Texas business, North Texas business, Dallas business, Dallas-Fort Worth business, DFW business, Texas nonprofit, North Texas nonprofit, Dallas nonprofit, Dallas-Fort Worth nonprofit, DFW nonprofit, symposium, symposia, non-profit, nonprofit, nonprofits, non-profits, cybersecurity, cyber security, north-texas, expo, vice president, Texas symposium, North Texas symposium, Dallas symposium, Dallas-Fort Worth symposium, DFW symposium,

    Nonprofit BUiLT is hosting the event to highlight the success and possibilities of Black tech talent in the region. “There is no talent pipeline problem,” says Peter Beasley, co-founder of the Blacks United in Leading Technology International. “Black tech talent is widely available, especially in North Texas.”

  • The NTXIA is a founding member of the new National Smart Coalitions Partnership, now one of the largest smart cities networks in the country. The organization unites more than 100 governments across seven regional smart cities consortiums. The goal? To accelerate sustainability and resilience in communities.

  • The U.S. Innovation and Competition Act, which passed in May, has the power to develop 20 tech hubs throughout the United States. According to Tech Titans' CEO Bill Sproull, Dallas-Fort Worth could be a strong contender for one of those spots.

  • Dr. Justin Lonon, vice chancellor of Dallas College, addresses the crowd at the recent Goldman Sachs 10,000 Small Businesses Dallas Graduation. [Photo: 10KSB]

    “There’s no one tougher and stronger than DFW small business owners," U.S. Representative Marc Veasey said at the event honoring the North Texas graduates. Here's the list of the 105 graduates and a rundown of the event. 10,000 Small Businesses also released insights from a recent research report. The survey says, among other findings, adaptation will be key to survival.

  • Lee Bratcher Texas Blockchain

    The inaugural October 8th Texas Blockchain Summit could be a watershed event for making Texas "the jurisdiction of choice" for Bitcoin and other digital currencies. Lee Bratcher, president of the Texas Blockchain Council, will host a wide array of speakers including Texas Senators John Cornyn and Ted Cruz and Wyoming Senator Cynthia Lummis.